Survival rate and perioperative data of patients who have undergone hemipelvectomy: a retrospective case series

World Journal of Surgical Oncology - Tập 14 - Trang 1-7 - 2016
Alfredo Guilherme Haack Couto1, Bruno Araújo2, Roberto André Torres de Vasconcelos3, Marcos José Renni4, Clóvis Orlando Da Fonseca5, Ismar Lima Cavalcanti1,6
1Department of Anesthesiology, Universidade Federal Fluminense, Niterói, Brazil
2Department of Anesthesiology, Instituto Nacional de Câncer José de Alencar Gomes da Silva, Rio de Janeiro, Brazil
3Department of Surgical Oncology, Instituto Nacional de Câncer José de Alencar Gomes da Silva, Rio de Janeiro, Brazil
4Hospital do Câncer II, Instituto Nacional de Câncer José de Alencar Gomes da Silva, Rio de Janeiro, Brazil
5Department of Neurosurgery, Universidade Federal Fluminense, Niterói, Brazil
6Instituto Nacional de Câncer José de Alencar Gomes da Silva, Rio de Janeiro, Brazil

Tóm tắt

Hemipelvectomy is a major orthopedic surgical procedure indicated in specific situations. Although many studies discuss surgical techniques for hemipelvectomy, few studies have presented survival data, especially in underdeveloped countries. Additionally, there is limited information on anesthesia for orthopedic oncologic surgeries. The primary aim of this study was to determine the survival rate after hemipelvectomy, and the secondary aims were to evaluate anesthesia and perioperative care associated with hemipelvectomy and determine the influence of the surgical technique (external hemipelvectomy [amputation] or internal hemipelvectomy [limb sparing surgery]) on anesthesia and perioperative care in Brazil. This retrospective case series collected data from 35 adult patients who underwent hemipelvectomy between 2000 and 2013. Survival rates after surgery were determined, and group comparisons were performed using the Kaplan–Meier method and the log-rank test. Mantel–Cox test and multiple linear regression analysis with stepwise forward selection were performed for univariate and multivariate analyses, respectively. Mean survival time was 32.8 ± 4.6 months and 5-year survival rate was 27 %. Of the 35 patients, 23 patients (65.7 %) underwent external hemipelvectomy and 12 patients (34.3 %) underwent internal hemipelvectomy. The survival rate was significantly higher in patients with bone tumors than in those with soft tissue sarcomas (P = 0.024). The 5-year cumulative probability of survival was significantly lower in patients who underwent external hemipelvectomy than in those who underwent internal hemipelvectomy (P = 0.043). In the univariate and multivariate analyses, only advanced disease stage (3 and 4) was identified as a significant independent predictor of reduced survival (P = 0.0003). Balanced general anesthesia combined with epidural block was the most frequent anesthesia technique. Median intraoperative crystalloid volume and red blood cell transfusions were 3500 mL and 2 units, respectively. Overall mean survival time after hemipelvectomy was 32.8 months. Advanced disease stage might be independently associated with reduced survival. Smaller amounts of fluids and transfusions were administered and time to discharge was shorter. Acute and chronic pain as well as wound complications are still important challenges in hemipelvectomy.

Tài liệu tham khảo

Baliski CR, Schachar NS, McKinnon JG, Stuart GC, Temple WJ. Hemipelvectomy: a changing perspective for a rare procedure. Can J Surg. 2004;47:99–103. Anderson MR, Jeng CL, Wittig JC, Rosenblatt MA. Anesthesia for patients undergoing orthopedic oncologic surgeries. J Clin Anesth. 2010;22:565–72. Guo Y, Fu J, Palmer JL, Hanohano J, Cote C, Bruera E. Comparison of postoperative rehabilitation in cancer patients undergoing internal and external hemipelvectomy. Arch Phys Med Rehabil. 2011;92:620–5. Smith RJ. Hemipelvectomy for trauma: case report. J Natl Med Assoc. 1991;83:265–8. Wedemeyer C, Kauther MD. Hemipelvectomy—only a salvage therapy? Orthop Rev (Pavia). 2011;3:e4. O’Connor MI. Malignant pelvic tumors: limb-sparing resection and reconstruction. Semin Surg Oncol. 1997;13:49–54. Harrington KD. The use of hemipelvic allografts or autoclaved grafts for reconstruction after wide resections of malignant tumors of the pelvis. J Bone Joint Surg Am. 1992;74:331–41. Apffelstaedt JP, Zhang PJ, Driscoll DL, Karakousis CP. Various types of hemipelvectomy for soft tissue sarcomas: complications, survival and prognostic factors. Surg Oncol. 1995;4:217–22. Penna V, Toller EA, Pinheiro CA, Becker RG. Hemipelvectomies: treatment, functional outcome and prognostic of the pelvic tumors. Acta Ortop Bras. 2011;19:328–32. Mankin HJ, Hornicek FJ. Internal hemipelvectomy for the management of pelvic sarcomas. Surg Oncol Clin N Am. 2005;14:381–96. Molnar R, Emery G, Choong PF. Anaesthesia for hemipelvectomy—a series of 49 cases. Anaesth Intensive Care. 2007;35:536–43. Enneking WF. Local resection of malignant lesions of the hip and pelvis. J Bone Joint Surg Am. 1966;48-A:991–1007. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. Daigeler A, Lehnhardt M, Khadra A, Hauser J, Steinstraesser L, Langer S, et al. Proximal major limb amputations—a retrospective analysis of 45 oncological cases. World J Surg Oncol. 2009;7:15. Cata JP, Gottumukkala V. Blood loss and massive transfusion in patients undergoing major oncological surgery: what do we know? ISRN Anesthesiol. 2012;2012:Article ID 918938. Mao L, Lin S, Lin J. The effects of anesthetics on tumor progression. Int J Physiol Pathophysiol Pharmacol. 2013;5:1–10. Tavare AN, Perry NJ, Benzonan LL, Takata M, Ma D. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer. 2012;130:1237–50. Heaney Á, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth. 2012;109:i17–28. Green JS, Tsui BC. Impact of anesthesia for cancer surgery: continuing professional development. Can J Anaesth. 2013;60:1248–69. Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anesthesiol. 2012;25:376–84. Weinbroum AA. Superiority of postoperative epidural over intravenous patient-controlled analgesia in orthopedic oncologic patients. Surgery. 2005;138:869–76. Beck LA, Einertson MJ, Winemiller MH, DePompolo RW, Hoppe KM, Sim FH. Functional outcomes and quality of life after tumor-related hemipelvectomy. Phys Ther. 2008;88:916–27. Houdek MT, Kralovec ME, Andrews KL. Hemipelvectomy: high-level amputation surgery and prosthetic rehabilitation. Am J Phys Med Rehabil. 2014;93:600–8. Lovich-Sapola J, Smith CE, Brandt CP. Postoperative pain control. Surg Clin N Am. 2015;95:301–18. Kehlet H, Rathmell JP. Persistent postsurgical pain: the path forward through better design of clinical studies. Anesthesiology. 2010;112:514–5. Higinbotham NL, Marcove RC, Casson P. Hemipelvectomy: a clinical study of 100 cases with five-year-follow-up on 60 patients. Surgery. 1966;59:706–8. Apffelstaedt JP, Driscoll DL, Karakousis CP. Partial and complete internal hemipelvectomy: complications and long-term follow-up. J Am Coll Surg. 1995;181:43–8. Apffelstaedt JP, Driscoll DL, Spellman JE, Velez AF, Gibbs JF, Karakousis CP. Complications and outcomes of external hemipelvectomy in the management of pelvic tumors. Ann Surg Oncol. 1996;3:304–9.